Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be Neuralink's next major technological update by end of 2025?
Increased electrode count • 25%
Extended battery life • 25%
New software features • 25%
Other major update • 25%
Neuralink press releases or major tech news outlets
Neuralink Implants Third Brain Device, Announces Updates and 2025 Plans at Las Vegas Event
Jan 11, 2025, 07:03 PM
Neuralink, the brain-computer interface company founded by Elon Musk, has successfully implanted its device in a third human patient. Musk announced during an event in Las Vegas, which was streamed on X, that all three implanted devices are functioning well. The company plans to conduct 20 to 30 more implants in 2025. The devices have been updated with additional electrodes and extended battery life. Neuralink is part of a growing field of startups developing brain implants aimed at treating conditions such as paralysis and ALS. The company is currently conducting two FDA-registered studies: the Prime Study, which allows paralyzed patients to control external devices like computers with their thoughts, and the Convoy Study, which explores controlling robotic arms. Neuralink's first patient, Noland Arbaugh, received the implant in 2024 and has used it to perform tasks such as navigating the internet and playing video games.
View original story
New treatment for epilepsy • 25%
Other significant milestone • 25%
Improved communication for paralyzed patients • 25%
Enhanced mobility for ALS patients • 25%
Paralysis treatment • 25%
ALS treatment • 25%
Blindness treatment • 25%
Other breakthrough • 25%
Other • 25%
Achieves full sensory feedback • 25%
Enables multi-device control • 25%
Significant AI integration • 25%
Case study on ALS treatment • 25%
Case study on paralysis treatment • 25%
No high-profile case study • 25%
Case study on other neurological conditions • 25%
Gaming • 25%
Other • 25%
Communication • 25%
Medical rehabilitation • 25%
No • 50%
Yes • 50%
Restoration of hand movement • 25%
Restoration of leg movement • 25%
Improvement in speech • 25%
Other • 25%
No • 50%
Yes • 50%
26 to 30 • 25%
More than 30 • 25%
Fewer than 20 • 25%
20 to 25 • 25%